Get the Weekly Intelligence Brief — top committee picks every Sunday.
ALGN · NASDAQ · STOCK

Align Technology (ALGN) Stock Analysis

Healthcare Updated August 24, 2026
$159.56
52W $122.00 – $200.44
60/100
$11.64B
28.2
1.65
AI Committee Verdict
Buy
60/100
Conviction: Contested · 50% agreement · 6 analysts
+16.6%
-0.2%
79.00:1
Contested

Is ALGN Bullish or Bearish?

Bullish. Innellis AI committee rates Align Technology (ALGN) Buy with a composite score of 60/100 , based on 6 analysts with 50% agreement. Last updated August 24, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +14.62 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -5.38 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.

Bull & Bear Case

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
  • Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock — Risk
Bear Case
  • P/E of 29.9 is moderate-to-rich — Value
  • EPS declining -2.5% YoY despite any revenue growth — Growth
  • MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 24, 2026
Overall Committee Score
60/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 34%
of 192 Healthcare peers
Value Analyst neutral
55 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− P/E of 29.9 is moderate-to-rich
Growth Analyst neutral
48 / 100 · High confidence
Moderate growth -- present but not remarkable
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− EPS declining -2.5% YoY despite any revenue growth
Technical Analyst neutral
54 / 100 · High confidence
Mixed or range-bound price action
+ Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement
− MACD histogram negative -- bearish momentum
Risk Analyst bullish
80 / 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
+ Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
60 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 3069.37)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 60.4 to 60.4.

Comparing 2026-08-23 to 2026-08-24 (1 day apart).

Technical Analysis

RSI (14)
37.4
Neutral
MACD Histogram
-1.426
Bearish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Lh Ll
Support
$162.26
Resistance
$189.59
Bollinger %B
0.10
Inside Bands
Price vs Moving Averages
EMA 9
$167.52 Below
EMA 21
$170.79 Below
EMA 50
$172.74 Below
EMA 200
$171.70 Below

Fundamental Analysis

Valuation
76
Growth
58
Profitability
67
Financial Health
75
Cash Flow
70
Valuation
P/E Ratio 28.2×
P/B Ratio 2.74×
PEG Ratio -9.84
Dividend Yield 0.00%
52W High $200.44
52W Low $122.00
Quality & Growth
ROE 1013.4%
ROA 658.3%
Gross Margin 6647.9%
Operating Margin 1333.1%
Revenue Growth YoY
Debt / Equity 0.03
AI Fundamental Assessment
P/E ratio of 28.2 (moderate relative to a 15-40x range); Price-to-book of 2.7x; PEG ratio of -9.8 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 10.1%; Return on assets of 6.6%; Net margin of 10.0%; Gross margin of 66.5%; Current ratio of 1.40 (tight short-term liquidity); Debt-to-equity of 0.03; Free cash flow per share is positive (10.58); Most recent quarter missed estimates by 0.9%; EPS growth accelerating (-21.6% -> +2.3% QoQ); Average YoY EPS growth of 6.0%; Analyst estimates falling over recent quarters
Get the Full ALGN Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime